Results 101 to 110 of about 778,689 (289)

Supplementary Data from Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors [PDF]

, 2023
Xuexin He, Jiali Ji, Xiaolan Dai, Aiham Qdaisat, Francisco J. Esteva, Gabriel N. Hortobágyi, Sai‐Ching J. Yeung   +6 more
openalex   +1 more source

ABC of Breast Diseases: Breast Cancer [PDF]

BMJ, 1994
J R, Sainsbury, T J, Anderson, D A, Morgan, J M, Dixon   +3 more
openaire   +2 more sources

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

Molecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga, María Luz Martinez‐Chantar, Carolina Conter   +2 more
wiley   +1 more source

Enhanced AkaLuc Bioluminescence Imaging for Longitudinal Intravital Monitoring of Minimal Residual Disease in a Murine Model of Triple-negative Breast Cancer [PDF]

Silvia Steinbauer, James Cowles, Mohammad A. Sabbaghi, Marle Poppelaars, A. Hussain, Marina Wagesreither, Daniela Laimer-Gruber, József Tóvári, Gergely Szakács, Agnes Csiszar   +9 more
openalex   +1 more source

Is prediction of local recurrence possible in Paget’s disease of the breast?

, 2022
Sevim Turanlı
openalex   +2 more sources

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and endoxan: a prospective randomized controlled clinical trial

BMC Cancer
Background Pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) is a treatment for preventing febrile neutropenia (FN) in patients with early breast cancer.
Yinggang Xu, Lifeng Huang, Jue Wang, Jinzhi He, Ye Wang, Weiwei Zhang, Rui Chen, Xiaofeng Huang, Jin Liu, Xinyu Wan, Wenjie Shi, Lu Xu, Xiaoming Zha   +12 more
doaj   +1 more source

Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey

, 2015
Rachel A. Freedman, Elena M. Kouri, Dee W. West, Shoshana M. Rosenberg, Ann H. Partridge, Joyce Lii, Nancy L. Keating   +6 more
openalex   +1 more source

Macrophagic “Crown-like Structures” Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease [PDF]

, 2017
Jodi M. Carter, Tanya L. Hoskin, Monica-Cătălina Pena, Rushin Brahmbhatt, Stacey J. Winham, Marlene H. Frost, Melody Stallings‐Mann, Derek C. Radisky, Keith L. Knutson, Daniel W. Visscher, Amy C. Degnim   +10 more
openalex   +1 more source

Benign Breast Disease and Breast Cancer [PDF]

New England Journal of Medicine, 2005
Kristiansen, Ivar S., Christensen, Palle M., Gyrd-Hansen, Dorte   +2 more
openaire   +3 more sources